ImmunoChem Therapeutics, LLC   Report issue

For profit Phase 1
Founded: Auburndale MA United States (2016)

Organization Overview

First Clinical Trial
2020
NCT04120233
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

ImmunoChem Therapeutics, LLC